title: Complete immunotolerance induction after FEIBA prophylaxis in a haemophilia A patient with high-titre inhibitor.
authors.forename: E
authors.initials: E
authors.lastname: Nanishi
authors.forename: S
authors.initials: S
authors.lastname: Ohga
authors.forename: T
authors.initials: T
authors.lastname: Doi
authors.forename: M
authors.initials: M
authors.lastname: Ishimura
authors.forename: K
authors.initials: K
authors.lastname: Ihara
authors.forename: H
authors.initials: H
authors.lastname: Takada
authors.forename: M
authors.initials: M
authors.lastname: Shima
authors.forename: T
authors.initials: T
authors.lastname: Hara
mesh_terms: D019774:Blood Coagulation Factor Inhibitors / Q000097:blood*; D001779:Blood Coagulation Factors / Q000627:therapeutic use*; D003029:Coagulants / Q000627:therapeutic use*; D005169:Factor VIII / Q000276:immunology; D006467:Hemophilia A / Q000188:drug therapy / Q000276:immunology*; D006470:Hemorrhage / Q000517:prevention & control*; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects*; D008297:Male; D055815:Young Adult
chemical_list: D019774:Blood Coagulation Factor Inhibitors; D001779:Blood Coagulation Factors; D003029:Coagulants; D005169:Factor VIII; C065655:anti-inhibitor coagulant complex